HPS Pharmacies wish to advise that bioCSL Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), have given notice of a drug recall of:
Red Back Spider Antivenom
500 units solution for injection
Lot Number: 053406301
This recall has been issued due to a potential for some vials from this batch to contain small fibres. The presence of fibres may compromise the sterility of the injection solution and may contribute to an increased risk of adverse events following administration.
Please inspect your stocks and quarantine all units from Lot Number 053406301, and then contact bioCSL Customer Service on 1800 008 275 to arrange return.
Supplies of red back spider antivenom are currently constrained and available stock from Lot Numbers 053406101 and 053406201 should be reserved for the treatment of critical cases. Until supplies return to normal, bioCSL have offered to facilitate the transfer of red back spider antivenom between hospitals, if required.
Retain this notice in a prominent position, including in other related business units for one month in case stock is in transit. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies, or bioCSL Customer Service directly on 1800 008 275.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.